Hemorragia y dosis bajas de heparina.

The role of T-helper cells in atherosclerosis.

Cardiovascular & hematological agents in medicinal chemistry·2010

Original Article: Insensitivity of Platelet Aggregation to Inhibition by Prostaglandin I(2) (PGI(2)) and Prostaglandin E(1) (PGE(1)), and Reduced Platelet c-AMP Accumulation in Response to PGE(1) in Insulin-dependent Diabetic Patients.

Platelets·2010

Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.

Journal of thrombosis and haemostasis : JTH·2010

The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

Current pharmaceutical design·2008

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.

International angiology : a journal of the International Union of Angiology·2008

Management of venous thromboembolism.

The Journal of the Association of Physicians of India·2007

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

No Germs, Just Cytokines: A Case of Immunotherapy-Induced Hemophagocytic Lymphohistiocytosis Masquerading as Neutropenic Sepsis in a Patient With Inflammatory Breast Cancer.

Cureus·2026

LigaSure™ Hemorrhoidectomy for Complex Grade III Hemorrhoidal Disease: A Prospective, Single-Center, Cohort Study.

Cureus·2026

Study on the predictive value of femoral head HU values in hip fractures.

Frontiers in surgery·2026

Atrial volume reduction correlates with early improvement in hemorrhage-associated normal pressure hydrocephalus-a 3D computed tomography volumetric study.

Frontiers in neurology·2026

Radially adjustable Tigertriever demonstrates higher reperfusion compared to self-expanding stent-retrievers during mechanical thrombectomy of large vessel occlusions: a systematic review and meta-analysis.

Frontiers in neurology·2026

Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke.

Frontiers in neurology·2026

Videos de Experimentos Relacionados

Hemorragia y dosis bajas de heparina

Videos de Conceptos Relacionados

The role of T-helper cells in atherosclerosis.

Original Article: Insensitivity of Platelet Aggregation to Inhibition by Prostaglandin I(2) (PGI(2)) and Prostaglandin E(1) (PGE(1)), and Reduced Platelet c-AMP Accumulation in Response to PGE(1) in Insulin-dependent Diabetic Patients.

Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.

The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.

Management of venous thromboembolism.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

No Germs, Just Cytokines: A Case of Immunotherapy-Induced Hemophagocytic Lymphohistiocytosis Masquerading as Neutropenic Sepsis in a Patient With Inflammatory Breast Cancer.

LigaSure™ Hemorrhoidectomy for Complex Grade III Hemorrhoidal Disease: A Prospective, Single-Center, Cohort Study.

Study on the predictive value of femoral head HU values in hip fractures.

Atrial volume reduction correlates with early improvement in hemorrhage-associated normal pressure hydrocephalus-a 3D computed tomography volumetric study.

Radially adjustable Tigertriever demonstrates higher reperfusion compared to self-expanding stent-retrievers during mechanical thrombectomy of large vessel occlusions: a systematic review and meta-analysis.

Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke.

Videos de Experimentos Relacionados

Hemorragia y dosis bajas de heparina

Videos de Conceptos Relacionados

Artículos Relacionados